I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.
The purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck.
head and neck carcinoma
neutrophil count
squamous cell carcinoma
skin cancer
second malignancy
- 0 views
- 19 Feb, 2024